Monitoring antimalarial drug efficacy [1] (multiple letters)

Clinical Infectious Diseases

Volumn 38, Issue 8, 2004, Pages 1192-1194

  Ringwald, P ^a   Mayxay, Mayfong ^b,c   Wewton, Paul N ^c,f   Khanthavong, Maniphono ^d   Tiengkham, Pongvongsa ^e   Phetsouvanh, Rattanaxay ^f   Phompida, Samlane ^d   Brockman, Alan ^g,h   White, Nicholas J ^b,f,g,h  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL UNIVERSITY OF LAOS   (Laos)

^c MAHOSOT HOSPITAL   (Laos)

^d Ctr Malariology   (Laos)

^e Savannakhet Provincial Malaria Station   (Laos)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^h MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

ANTIMALARIAL ACTIVITY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; HUMAN; LETTER; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; ANIMAL; DRUG EFFECT; DRUG MONITORING; DRUG RESISTANCE; LAOS; MALARIA FALCIPARUM; NOTE; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG MONITORING; DRUG RESISTANCE; HUMANS; LAOS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TREATMENT FAILURE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 2342614949     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383152     Document Type: Letter

References (0)